[go: up one dir, main page]

NO20071385L - Multivalent hundevaksine mot leptospira Bratislava og andre patogener - Google Patents

Multivalent hundevaksine mot leptospira Bratislava og andre patogener

Info

Publication number
NO20071385L
NO20071385L NO20071385A NO20071385A NO20071385L NO 20071385 L NO20071385 L NO 20071385L NO 20071385 A NO20071385 A NO 20071385A NO 20071385 A NO20071385 A NO 20071385A NO 20071385 L NO20071385 L NO 20071385L
Authority
NO
Norway
Prior art keywords
canine
caused
leptospira
pathogens
virus
Prior art date
Application number
NO20071385A
Other languages
English (en)
Inventor
Joseph Claude Frantz
Thomas Jack Newby
Cassius Mcallister Tucker
Original Assignee
Zoetis P Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35657262&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20071385(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Zoetis P Llc filed Critical Zoetis P Llc
Publication of NO20071385L publication Critical patent/NO20071385L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/23—Parvoviridae, e.g. feline panleukopenia virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/0225—Spirochetes, e.g. Treponema, Leptospira, Borrelia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/099—Bordetella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
    • A61K39/175—Canine distemper virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/215—Coronaviridae, e.g. avian infectious bronchitis virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/235—Adenoviridae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55577—Saponins; Quil A; QS21; ISCOMS
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/20011—Papillomaviridae
    • C12N2710/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14311—Parvovirus, e.g. minute virus of mice
    • C12N2750/14334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18411—Morbillivirus, e.g. Measles virus, canine distemper
    • C12N2760/18434—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)

Abstract

Det beskrives vaksiner og fremgangmåter for å beskytte hunder mot sykdommer forårsaket av Leptospira bratislava. Oppfinnelsen vedrører også kombinasjonsvaksiner og fremgangsmåter for å beskytte hunder mot sykdommer eller forstyrrelser forårsaket av hundepatogener, for eksempel smittsom luftveisbronkitt forårsaket av Bordetella bronchiseptica, canine distemper forårsaket av canine distemper (CD) virus, smittsom canine hepatitt (ICH) forårsaket av canine adenovirus type 1 (CAV-1), respirasjonssykdom forårsaket av canine adenovirus type 2 (CAV-2), canine parainfluensavirus (CPI) virus, enterititt forårsaket av canine coronavirus (CCV) og canine parvovirus (CPV), og leptospirose forårsaket av Leptospira bratislava, Leptospira canicola, Leptospira grippotyphosa, Leptospira icterohaemorrhagiae eller Leptospira pomona.
NO20071385A 2004-10-06 2007-03-15 Multivalent hundevaksine mot leptospira Bratislava og andre patogener NO20071385L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/959,757 US20050089533A1 (en) 2003-01-29 2004-10-06 Canine vaccines against Bordetella bronchiseptica
PCT/IB2005/003111 WO2006038115A1 (en) 2004-10-06 2005-09-23 Multivalent canine vaccines against leptospira bratislava and other pathogens

Publications (1)

Publication Number Publication Date
NO20071385L true NO20071385L (no) 2007-04-18

Family

ID=35657262

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20071385A NO20071385L (no) 2004-10-06 2007-03-15 Multivalent hundevaksine mot leptospira Bratislava og andre patogener

Country Status (26)

Country Link
US (2) US20050089533A1 (no)
EP (1) EP1799253B1 (no)
JP (2) JP4163245B2 (no)
KR (3) KR20070050499A (no)
CN (2) CN101035558B (no)
AT (1) ATE524193T1 (no)
AU (1) AU2005290921C1 (no)
BR (1) BRPI0516253A (no)
CA (1) CA2583689C (no)
CY (1) CY1114897T1 (no)
DK (1) DK1799253T3 (no)
ES (1) ES2370750T3 (no)
FR (2) FR14C0079I1 (no)
LU (2) LU92136I2 (no)
ME (1) ME01306B (no)
MX (1) MX2007004133A (no)
NO (1) NO20071385L (no)
NZ (3) NZ576898A (no)
PL (1) PL1799253T3 (no)
PT (1) PT1799253E (no)
RS (1) RS52035B (no)
RU (1) RU2400248C2 (no)
SI (1) SI1799253T1 (no)
UA (1) UA91197C2 (no)
WO (1) WO2006038115A1 (no)
ZA (1) ZA200702166B (no)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008032796A1 (fr) * 2006-09-13 2008-03-20 Nippon Zenyaku Kogyo Co., Ltd. Nouveau vaccin canin
US20050089533A1 (en) * 2003-01-29 2005-04-28 Joseph Frantz Canine vaccines against Bordetella bronchiseptica
EP2452693A3 (en) * 2005-10-07 2012-06-06 Pfizer Products Inc. Vaccines and methods to treat canine influenza
US7468187B2 (en) * 2005-10-18 2008-12-23 Iowa State University Research Foundation, Inc. Canine influenza virus and related compositions and methods of use
US7682619B2 (en) * 2006-04-06 2010-03-23 Cornell Research Foundation, Inc. Canine influenza virus
UA99719C2 (ru) * 2006-11-03 2012-09-25 Шеринг-Плау Лтд. Вакцина для собак против болезни лайма
AU2015255165A1 (en) * 2006-12-27 2015-11-26 Zoetis Services Llc Methods of vaccine administration
NZ577855A (en) * 2006-12-27 2012-07-27 Pfizer Prod Inc Vaccination schedule to prevent canine disease
SI2134742T1 (sl) 2007-02-27 2012-09-28 Wyeth Llc Imunogene zmesi za zdravljenje in prepreäśevanje ĺ˝ivalskih okuĺ˝b
US7878586B2 (en) * 2007-10-29 2011-02-01 The Boeing Company System and method for an anticipatory passenger cabin
CA2710186C (en) * 2007-12-21 2015-11-03 Pfizer Inc. Heat treated bacterins, and emulsion vaccines prepared from such heat treated bacterins
JP2013507925A (ja) * 2009-10-14 2013-03-07 ザ・ボード・オブ・リージェンツ・フォー・オクラホマ・ステート・ユニバーシティ アライグマからのイヌパルボウイルス−２に関連するウイルスの分離
CN103153337A (zh) 2010-09-28 2013-06-12 共立制药股份有限公司 黏膜佐剂组合物
RS61723B1 (sr) * 2011-02-04 2021-05-31 Zoetis Services Llc Imunogenične bordetella bronchiseptica kompozicije
JP5833144B2 (ja) * 2011-02-04 2015-12-16 ゾエティス・エルエルシー イヌ呼吸器病症候群のための組成物
CN102343088B (zh) * 2011-10-14 2013-02-13 浙江诺倍威生物技术有限公司 一种犬传染性气管支气管炎二联活疫苗及其制备方法
CN104582720B (zh) 2012-08-17 2017-10-27 英特维特国际股份有限公司 灭活钩端螺旋体属细菌的免疫原性组合物
DK2884996T3 (da) * 2012-08-17 2020-03-09 Intervet Int Bv Immunogen sammensætning af dræbte leptospira-bakterier
US9314519B2 (en) * 2012-08-21 2016-04-19 Intervet Inc. Liquid stable virus vaccines
CZ307883B6 (cs) * 2013-01-29 2019-07-24 Bioveta, A.S. Multivalentní vakcína k imunoprofylaxi infekčních onemocnění psů
RU2546247C2 (ru) * 2013-06-06 2015-04-10 Автономная некоммерческая организация "Научно-исследовательский институт диагностики и профилактики болезней человека и животных" (АНО "НИИ ДПБ") Вакцина против чумы, аденовирусных инфекций, парвовирусного и коронавирусного энтеритов, лептоспироза и бешенства собак
KR101622554B1 (ko) 2014-07-16 2016-05-19 (주)양성그린바이오 면역항체를 이용한 강아지질병의 치료용 조성물의 제조방법
EP3909971A1 (en) 2020-09-28 2021-11-17 Institute of Life Sciences (ILS) Whole cell livestock vaccine for respiratory diseases
CN117187118B (zh) * 2023-08-16 2024-07-23 华中农业大学 一株支气管败血波氏杆菌a1218及其应用

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3470294A (en) * 1961-06-21 1969-09-30 Behringwerke Ag Vaccine for immunization of dogs and foxes against distemper,hepatitis contagiosa and leptospirosis and process for preparing it
US4567042A (en) * 1983-06-15 1986-01-28 American Home Products Corporation Inactivated canine coronavirus vaccine
US4567043A (en) * 1983-06-15 1986-01-28 American Home Products Corporation (Del.) Canine corona virus vaccine
US4888169A (en) * 1986-10-14 1989-12-19 Norden Laboratories, Inc. Bordetella Bronchiseptica vaccine
RU2030915C1 (ru) * 1990-10-31 1995-03-20 Всероссийский государственный научно-исследовательский институт контроля, стандартизации и сертификации ветеринарных препаратов Вакцина против лептоспироза животных
JP2521226B2 (ja) * 1993-01-28 1996-08-07 株式会社微生物化学研究所 犬用多種混合ワクチン
WO1994022475A1 (en) * 1993-03-31 1994-10-13 The Regents Of The University Of California Cloned leptospira outer membrane protein
UA56132C2 (uk) * 1995-04-25 2003-05-15 Смітклайн Бічем Байолоджікалс С.А. Композиція вакцини (варіанти), спосіб стабілізації qs21 відносно гідролізу (варіанти), спосіб приготування композиції вакцини
AUPO549497A0 (en) * 1997-03-07 1997-03-27 Agriculture Victoria Services Pty Ltd Novel bacterial pathogens
US6306623B1 (en) * 1998-02-24 2001-10-23 The University Of California Leptospiral major outer membrane protein LipL32
NZ501213A (en) * 1998-12-22 2001-09-28 Pfizer Prod Inc Isolated leptospira membrane kinase, membrane permease, membrane mannosyltransferase and endoflagellin proteins for preventing leptospirosis
US20020058039A1 (en) * 2000-04-27 2002-05-16 Coyne Michael J. Method of measuring the duration of adequate immune memory in companion animals
US20030129161A1 (en) * 2001-09-17 2003-07-10 Hsien-Jue Chu Interleukin-12 as a veterinary vaccine adjuvant
CA2486345C (en) * 2002-05-17 2012-08-14 Fundacao Oswaldo Cruz - Fiocruz Proteins with repetitive bacterial-ig-like (big) domains present in leptospira species
EP1743652B1 (en) * 2002-08-26 2011-11-16 Pfizer Products Inc. Vaccine for respiratory and reproductive system infections in cattle
CN1835767A (zh) 2003-01-29 2006-09-20 辉瑞产品公司 对抗支气管败血性博德特氏杆菌的犬疫苗
US20050089533A1 (en) * 2003-01-29 2005-04-28 Joseph Frantz Canine vaccines against Bordetella bronchiseptica
NZ577855A (en) * 2006-12-27 2012-07-27 Pfizer Prod Inc Vaccination schedule to prevent canine disease

Also Published As

Publication number Publication date
LU92136I2 (fr) 2013-03-18
FR14C0078I1 (fr) 2014-12-19
US20050089533A1 (en) 2005-04-28
RU2400248C2 (ru) 2010-09-27
JP4163245B2 (ja) 2008-10-08
DK1799253T3 (da) 2011-11-28
CY1114897T1 (el) 2016-12-14
KR20070050499A (ko) 2007-05-15
AU2005290921B2 (en) 2010-07-08
JP2008239627A (ja) 2008-10-09
LU92135I9 (no) 2019-01-04
BRPI0516253A (pt) 2008-08-26
ES2370750T3 (es) 2011-12-22
KR101226869B1 (ko) 2013-01-25
CA2583689A1 (en) 2006-04-13
US20080175860A1 (en) 2008-07-24
MX2007004133A (es) 2007-06-15
FR14C0079I1 (fr) 2014-12-19
CN101035558A (zh) 2007-09-12
RS52035B (sr) 2012-04-30
ME01306B (me) 2013-12-20
LU92136I9 (no) 2019-01-04
CA2583689C (en) 2013-06-11
LU92135I2 (fr) 2013-03-18
JP2008515873A (ja) 2008-05-15
KR20120031294A (ko) 2012-04-02
CN101791398A (zh) 2010-08-04
PT1799253E (pt) 2011-11-10
ATE524193T1 (de) 2011-09-15
NZ553867A (en) 2010-10-29
RU2007112480A (ru) 2008-11-20
NZ576898A (en) 2011-03-31
CN101035558B (zh) 2011-04-06
EP1799253B1 (en) 2011-09-14
AU2005290921A1 (en) 2006-04-13
SI1799253T1 (sl) 2011-11-30
KR20080096610A (ko) 2008-10-30
EP1799253A1 (en) 2007-06-27
AU2005290921C1 (en) 2012-10-11
NZ591422A (en) 2012-09-28
WO2006038115A1 (en) 2006-04-13
PL1799253T3 (pl) 2012-01-31
UA91197C2 (ru) 2010-07-12
ZA200702166B (en) 2008-11-26
HK1112839A1 (en) 2008-09-19

Similar Documents

Publication Publication Date Title
NO20071385L (no) Multivalent hundevaksine mot leptospira Bratislava og andre patogener
TW200505476A (en) Canine vaccines against bordetella bronchiseptica
Day et al. Aetiology of canine infectious respiratory disease complex and prevalence of its pathogens in Europe
AR064530A1 (es) Procedimientos para la administracion de vacunas
RU2015109724A (ru) Жидкие стабильные вирусные вакцины
PE20040420A1 (es) Vacunas para enfermedades reproductivas del ganado
CL2008003845A1 (es) Vacuna que comprende una emulsion, una bacterina tratada termicamente a 55-70°c por 5-10 horas, que comprende una suspension de bacterias muertas de la especie leptospira bratislava, y de 1 a 13 virus causantes de enfermedad porcina.
WO2004093904A3 (en) Modified live vaccines comprising bhv-1(ibr) and/or bvdv pregnant and nursing cattles
BRPI0407436A (pt) Composições adesivas para dentaduras, bem como método para a obtenção de efeito antiplaca
WO2008106393A3 (en) Immunogenic compositions and methods for treating and preventing animal infections
TH71070A (th) วัคซีนสุนัขต้าน Bordetella bronchiseptica
RU2006133328A (ru) Способ вакцинации против инфекции семенников bvdv
RU2025100978A (ru) Вакцина для защиты против leptospira серовара icterohaemorrhagiae
RU2013126074A (ru) Вакцина против чумы, аденовирусных инфекций, парвовирусного и коронавирусного энтеритов, лептоспироза и бешенства собак
Rodes Moltó Eurican: the recent innovation.
CO5690616A2 (es) Vacunas para enfermedades reproductoras del ganado
DK1204421T3 (da) Stressprotein-peptidkomplekser som vacciner mod intracellulære patogener
AR045152A1 (es) Vacunas virales mutantes
Trudel et al. Efficient intranasal vaccination of mice against human respiratory syncytial virus with an experimental iscoms subunit vaccine
TH94300A (th) องค์ประกอบก่อภูมิคุ้มกัน pcv2 ชนิดมัลติเวเลนต์ และวิธีของการผลิตองค์ประกอบเหล่านี้

Legal Events

Date Code Title Description
CHAD Change of the owner's name or address (par. 44 patent law, par. patentforskriften)

Owner name: ZOETIS P LLC, US

CHAD Change of the owner's name or address (par. 44 patent law, par. patentforskriften)

Owner name: ZOETIS SERVICES LLC, US

CHAD Change of the owner's name or address (par. 44 patent law, par. patentforskriften)

Owner name: ZOETIS SERVICES LLC, US